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Abstract

BMP-SIGNALING REGULATES A COMMON TRANSCRIPTIONAL PROGRAM
TO CONTROL FACIAL FORM AND SKELETAL MORPHOGENESIS

Publication No._______
Margarita Bonilla-Claudio, B.S.
Supervisory Professor: James F. Martin, M.D., Ph.D.

Much of the craniofacial skeleton, such as the skull vault, mandible and midface,
develops through direct, intramembranous ossification of the cranial neural crest
(CNC) derived progenitor cells.

Bmp-signaling plays critical roles in normal

craniofacial development, and Bmp4 deficiency results in craniofacial abnormalities,
such as cleft lip and palate. We performed an in depth analysis of Bmp4, a critical
regulator of development, disease, and evolution, in the CNC. Conditional Bmp4
overexpression, using a tetracycline regulated Bmp4 gain of function allele, resulted
in facial form changes that were most dramatic after an E10.5 Bmp4 induction.
Expression profiling uncovered a signature of Bmp4 induced genes (BIG)
composed predominantly of transcriptional regulators controlling self-renewal,
osteoblast differentiation, and negative Bmp autoregulation.

The complimentary

experiment, CNC inactivation of Bmp2, Bmp4, and Bmp7, resulted in complete or
partial loss of multiple CNC derived skeletal elements revealing a critical
requirement for Bmp-signaling in membranous bone and cartilage development.

v

Importantly, the BIG signature was reduced in Bmp loss of function mutants
indicating similar Bmp-regulated target genes underlying facial form modulation and
normal skeletal morphogenesis. Chromatin immunoprecipitation (ChIP) revealed a
subset of the BIG signature, including Satb2, Smad6, Hand1, Gadd45γ and Gata3
that was bound by Smad1/5 in the developing mandible revealing direct, Smadmediated regulation. These data indicate that Bmp-signaling regulates craniofacial
skeletal development and facial form by balancing self-renewal and differentiation
pathways in CNC progenitors.
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Introduction

1

The cranial neural crest (CNC) cells are a migratory cell population that
originates from the dorsal neural tube during neurulation (Fig. 1 A). CNC diversifies
into multiple cell types including cartilage, bone, smooth muscles, neurons, glia, and
connective tissues of the blood vessels.

Migration of the CNC occurs in three

recognized streams, trigeminal, hyoid, and post-octic (Fig. 1 B). Each stream has
been traced from their origin to their final fate. CNC arising from rhombomers 1 and
2, forms the trigeminal ganglion neurons and craniofacial components, including the
mandible. Meanwhile, CNC originating from rhombomere 4 give rise to neurons of
the proximal facial ganglion and hyoid skeleton.

Lastly, CNC originating from

rhombomere 6 and 7 forms neurons of the proximal jugular ganglia and pharyngeal
arches skeletal components (Graham et al., 2004).
Much of the craniofacial skeleton components, including the skull vault or
calvarium, mandible, and midface develops through direct, intramembranous
ossification of CNC-derived progenitor cells (Fig. 2) (Chai and Maxson, 2006). For
example, in the skull, osteogenesis occurs at discrete areas within the cranial
mesenchyme resulting in the flat bones of the skull forming between the central
nervous system (CNS) and overlying ectoderm (Jiang et al., 2002). The mandible
and most midfacial bones develop by direct ossification of CNC-derived branchial
arch mesenchyme (Nie et al., 2006).
The complexity of neural crest cell formation involves a number of key
signaling regulators, such as those mediated by the Wnt, Fibroblast growth factor
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Figure 1. Formation and migration of the CNC.
(A) CNC is induced at the neural plate border. After neurulation, delamination of
cells between the ectoderm and the dorsal neural tube give rise to CNC (Knecht
and Bronner-Fraser, 2002). (B) Migration of the CNC occurs in three recognized
streams, trigeminal (red), hyoid (green), and post-octic (purple) (Graham et al.,
2004).
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Figure 2. Origin of the skeletal elements of the skull.
Adult mouse skull showing the CNC- and mesoderm- derived bones (Noden and
Trainor, 2005).
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(Fgf) and Bone morphogenic protein (Bmp) pathways (Knecht and Bronner-Fraser,
2002). For example, studies have shown the importance of Bmp-signaling in the
specification of the neural plate and neural crest cells (Tribulo et al., 2003).
Furthermore, migration of the CNC cells to the facial primordia also involves the
participation of Bmp-mediated signaling. Inhibition of Bmp2 and Bmp4 in the CNC
results in hypomorphic branchieal arches, while neural and skeletal derivates did
not develop (Kanzler et al., 2000).
Bmp-signaling plays a critical role in normal craniofacial development.
Several studies have elegantly demonstrated that Bmp4 deficiency results in
craniofacial anomalies, such as cleft lip and palate, in mouse and humans (Liu et
al., 2005b; Suzuki et al., 2009). In the mandible, Bmp4 has been shown to regulate
proximo-distal patterning and timing of bone differentiation in mandibular
mesenchyme (Liu et al., 2005a; Merrill et al., 2008). There is strong evidence that
Bmp-signaling regulates craniofacial morphologic change during evolution. Both
gain of function studies and comparative expression data revealed Bmp4 to be a
critical regulator of beak shape in Darwin’s finches, a classic model of evolutionary
diversification (Abzhanov et al., 2004; Wu et al., 2004). Other experiments in Cichlid
fish also support the notion that Bmp4 is a major regulator of craniofacial cartilage
shape and morphologic adaptive radiation (Albertson et al., 2005). In summary,
while the role of Bmp-signaling in craniofacial development has been well studied,
the downstream genes regulated in response to Bmp-signaling remain poorly
understood.
5

Recent molecular insights into Bmp-signaling indicate that the downstream
effector mechanisms for Bmp-signaling are complex and require further study
(Wang et al., 2011).

The canonical Bmp pathway involves nucleo-cytoplasmic

shuttling of Smad effectors in response to Bmp-signaling. Bmp, as members of the
TGF family, are dimeric ligands that bind to a pair of membrane BMP receptor type I
and type II (BMPRI and BMPRII). These serine/threonine kinase receptors form a
hetero-tetramer receptor complex, while type II receptors can phosphorylate type I
receptors at the cytoplasmic region.

Upon phosphorylation, a docking site is

created that enables receptor-regulated Smad proteins (Smad1, Smad5 and
Smad8) binding and further activation (Massague et al., 2005). Phosphorylated
receptor-regulated Smad protein can then associate with Smad4 and form a
heterodimer complex capable of regulating gene expression (Nohe et al., 2004).
In addition, several studies have shown that Smad-independent mechanisms
mediated through MAPK pathways, can play an important role in tooth development
(Xu et al., 2008). More recent work, uncovered a third Bmp effector mechanism,
revealing that Smad1/5 can directly bind to the Drosha complex to promote
microRNA (miR) processing (Davis et al., 2008). Furthermore, our group has shown
that Bmp-signaling can induce miR transcription through a canonical Smad
regulated mechanism (Wang et al., 2010).

Despite the central importance of Bmp

signaling for craniofacial development, congenital defects, and evolution, the
mechanisms underlying Bmp action in CNC remains poorly understood.
In this study, we investigated Bmp signaling in CNC development using both
gain and loss of function approaches. Inactivation of Bmp2, Bmp4, and Bmp7 in
6

CNC indicate that Bmp2 and Bmp4 are the major Bmp ligands required for
development of CNC-derived bone and cartilage. Moreover, gain of function studies
indicate that elevated Bmp4 in CNC results in dramatic changes in facial shape.
Expression profiling and quantitative RT-PCR (qRT-PCR) studies uncovered a
common set of Bmp-regulated target genes in both gain and loss of function
embryos. Subsets of Bmp-regulated targets were directly bound by Smad 1/5
indicating direct regulation. Our data suggest a role for Bmp-regulated genes to
modulate self-renewal, osteoblast differentiation, and negative feedback regulation.
Moreover, we suggest that Bmp signaling is a key player in skeletal morphogenesis
and facial shape by controlling the balance between self-renewing progenitors and
differentiating lineage restricted cells. Negative feedback regulation, a mechanism
used to finely modulate Bmp-signaling levels, is likely a general output of Bmpsignaling in multiple contexts.

7

Materials and Methods

8

Mouse alleles and transgenic lines.
The generation and characterization of Bmp2 and Bmp4 conditional null mice
and Wnt1Cre transgene mice have been previously described (Liu et al., 2004; Ma
and Martin, 2005 and Chai, 2000). The conditional Bmp7 null allele will be
described elsewhere (Bai Y and Martin JF, unpublished) (Appendix 1).
To generate the Bmp4TetO allele we constructed a targeting vector that
resulted in a 665 bp deletion upstream of and including the Bmp4 basal promoter
and Bmp4 exon 1.

We modified the TetO plasmid that was a kind gift from

Raymond MacDonald laboratory at The University of Texas Southwestern Medical
Center. The plasmid contains the tetracycline operator (TetO7), CMV promoter,
IRES-lacZ and a poly-adenylation sequence. Bmp4 genomic DNA was isolated
from the 129/S BAC library. A 9-kb EcoRI fragment of Bmp4 genomic DNA was
subcloned into pBluescript (Stratagene). We inserted Bmp4 cDNA into NotI and
KasI sites downstream of the TetO7 and CMV promoter.

The phosphoglycerol

kinase neomycin-resistance cassette (pgk-neo) with two flanking Frt sites was blunt
cloned into the AscI site downstream of the IRES-LacZ. The 3 kb 3’ homology arm
was amplified by PCR using the primers (5’-3’) tgagcagggcaacctggagaggg and
tccgaatggcactacggaatggct and blunt end ligated into SwaI site downstream of pgkneo.

The Bmp4TetO 5’ arm, 1.7 kb EcoRI-ApaLI fragment, was cut from Bmp4

genomic DNA and blunt end cloned into XhoI site upstream of the tetO7. The
targeting construct was linearized with PmeI and electroporated into AK7 embryonic
stem cells, selected in G418, and screened by Southern blot.

The cells were
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digested with EcoRV and Bmp4 Exon 4 was used as the 3’ flanking probe. Wild
type allele gives a 22 kb EcoRV fragment and the targeted allele give a 16kb
EcoRV fragment. The targeting frequency for the TetO allele is 4.2% (7/167). We
also used a Spe1 digest to confirm correct targeting: the wild type band was 6.4 kb,
the cDNA band was 11.7 kb, and the mutant allele was 8.0 kb. We used the Rosa
26 rtTA allele (Belteki et al., 2005) to express the reverse tetracycline activator (Teton) under the control of the Wnt1cre allele. This will drive Bmp4TetO allele expression
on the neural crest cells in the presence of doxycycline.

Doxycycline administration in mice.
Pregnant females were given doxycycline (Sigma) in the drinking water
(2mg/ml) and in the food (Bio-Serv; 200mg/kg), for a 24 hour period unless
otherwise specified.

Skeletal analysis.
Dissected embryos were placed overnight in water and scalded in hot water
for 30 seconds. The skin and internal organs were removed and the samples were
fixed overnight in 95% ethanol. The cartilage was stained with 0.15mg/ml Alcian
Blue (Sigma) in a 1:4 mixture of glacial acetic acid and 95% ethanol. After staining
overnight, the samples were rinsed twice in 95% ethanol and incubated for 24 hrs in
95% ethanol. In preparation for bone staining, samples were placed in 2% KOH for
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1 hr. Bones were stained using 0.05mg/ml of Alizarin red (Sigma) diluted in 2%
KOH for 2-4 hrs and then cleared with glycerol.

Alkaline Phosphatase staining.
E14.5

embryos

were

dissected,

decapitated

and

fixed

in

4%

paraformaldehyde for 1 hour. Heads were bisected mid-sagittally and the brain and
dura mater removed, washed three times in phosphate buffered saline
(PBS) and Alkaline phosphatase buffer (100mM NaCl; 100mM TrisHCl pH 9.5;
50mM MgCl2; 0.1% Tween-20; 2mM Levimasole). A combination of nitro-blue
tetrazolium chloride and 5-bromo-4-chloro-3’-indolyphosphate p-toluidine salt
(NBT/BCIP) (Roche) substrate in Alkaline phosphatase buffer was added until bone
staining was observed. Samples were then washed in PBS, and post-fixed in 4%
paraformaldehyde.

Western Blot
Cell lysates were prepared by dissecting E11.5 mandibles in PBS. Tissue
was then homogenized in lysis buffer (50 mmol/L Tris, 150 mmol/L NaCl, 1% Triton
X-100 (Bio-Rad), 0.5% deoxycholate (Sigma) plus protease inhibitors cocktail
(Roche), EDTA, and sodium vanadate (Sigma). Sample protein concentration was
determined by the Protein Assay Reagent kit (Pierce). Whole cell lysates were
separated by 12% SDS-PAGE and transferred to nitrocellulose. Blots were blocked
with 5% nonfat milk at room temperature for 1 hour. Blots were incubated with the
11

p-Smad1/5/8 polyclonal antibody (1:1,000 dilution; Cell Signaling) and Smad 1/5/8/
polyclonal antibody (1:1,000 dilution; Santa Cruz) at room temperature with
agitation for 1 hour, followed by incubation with anti-rabbit IgG horseradish
peroxidase–conjugated antibody (1:2,000; GE Healthcare). Blots were developed
using an enhanced chemiluminescence detection kit (ECL; Pierce). To confirm
equal loading we used anti–β-actin antibody (1:5,000; Sigma). Western Blots were
quantified by densitometry analysis using Image J software (NIH).

Whole mount in situ hybridization.
We thank James Douglas Engel, Richard Maas, Robert E. Maxson Jr, Sylvia
Evans and Stephen E. Harris for providing Gata3, Msx1, Msx2, Tbx20 and Bmp4 in
situ probes.

Plasmids for in situ probes have been previously described: Dlx6

(Charite et al., 2001), Gata3 (Ruest et al., 2004b), Hand1 (McFadden et al., 2005),
Smad6 (Ma et al., 2005), Msx1 (Ishii et al., 2005) , Msx2 (Ishii et al., 2003), and
Tbx20 (Shen et al., 2011). Full-length cDNA for mouse BMP4 was provided by Dr.
Stephen Harris and was linearized with SpeI and transcribe with T7. Exon 3 and 4,
including 3’UTR of Gadd45γ were amplified and subcloned into T-easy vector.
Plasmid was linearized with EcoRV and transcribe with T7 RNA polymerase. Cux2
(exon 23) and Satb2 (exon10) were amplified and subcloned into T-easy vector.
Plasmid was linearized with SacI and transcribe with T7 RNA polymerase.
Whole mount in situ hybridization were performed as follows: embryos were
fixed overnight in 10% formalin then dehydrated in 100% methanol overnight until
12

genotype were confirmed.

Embryos were re-hydrated in a graded series of

methanol/PBS-Tween and treated with 10µl/ml of proteinase K for 15 minutes
followed by 10 minute treatment with 2mg/ml glycine.
hybridization

at

70°C,

embryos

were

fixed

for

Before overnight probe
20

minutes

with

4%

paraformaldehyde. Embryos were washed and pre-blocked with 10% sheep serum
before overnight incubation with anti-Digoxigening-AP (Roche) at 4°C. Additional
washes were performed with TBST before detection with NBT/BCIP (Roche). For all
experiments, at least three mutants and three controls embryos were analyzed for
each probe.

Quantitative Real Time PCR and Microarray.
E11.5 mandibles were dissected in cold PBS and placed in RNAlater
(Ambion) for RNA stabilization. mRNA was then extracted using the RNeasy Micro
Kit (Qiagen).

First strand cDNA synthesis was then performed utilizing the

SuperScript™ II Reverse Transcriptase kit (Invitrogen) with 500ng of mRNA.
Quantitative Real-Time PCR was performed using SYBR Green QPCR Master Mix
(Invitrogen) in triplicate reactions and ran on Mx3000P thermal cycler (Stratagene).
Primers used in this study are listed in Appendix 2. For all qRT-PCR experiments,
at least three mutants and three control embryos were analyzed. DNA microarray
analysis, including gene ontology analysis, was performed using the OneArray™
Mouse Whole Genome Array (Phalanx Biotech Group). Mandibular processes were
pooled to collect a minimally required RNA amount: seven Bmp4 OE and five
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controls embryos were used. Gene ontology results were confirmed using DAVID
Bioinformatics Resources 6.7 National Institute of Allergy and Infectious Diseases
(NIAID), NIH.

Chromatin immunoprecipitation.
Chromatin immunoprecipitation (ChIP) analysis was performed as previously
described (Wang et al., 2010). We used E11.5 wild type mice mandibles and the
mouse osteoblastic cell line MC3T3-E1 (ATCC).

Cells were maintained and

propagated following ATCC protocols. Experiments were performed with 90%
confluent cultures and Bmp4 (R&D System) was added to the media for a final
concentration of 25pg/µl for 12hrs. Primer sequences used for amplification of the
Bmp/Smad regulatory elements are found in Apendix 2.

Sequence analysis
For sequence analysis and multiple sequence alignment, Ensembl genome
database and MAFFT (http://mafft.cbrc.jp/alignment/server/) were used.

14

Results

15

Bmp2, Bmp4, and Bmp7 deletion in cranial neural crest results severe loss of
cranial bone.
We used the Wnt1cre driver and a Bmp4 conditional null allele, Bmp4floxneo to
inactivate Bmp4 in CNC (Chai et al., 2000; Liu et al., 2004). Intercrosses between
Wnt1cre; Bmp4
Bmp4

floxneo/+

floxneo;floxneo (f/f)

with Bmp4floxneo homozygous mice generated Wnt1cre;

mutant embryos, hereafter called Bmp4 CKO. Evaluation of

skull preparations indicated that Bmp4 CKO mutant newborn skulls had enlarged
frontal fontanelle and subtle mandibular defects (Fig. 4 A-B). Examination of Msx1
and Msx2 expression, markers of preosteogenic head mesenchyme, revealed that
these markers were reduced, but still present, in the Bmp4 CKO embryos (Fig. 3 AD). Alkaline phosphatase, a marker of both preosteoblasts and mature osteoblasts,
was also reduced in the frontal bone of Bmp4 CKO embryos, indicating a defect in
the transition from pre-osteoblast to osteoblast in the Bmp4 CKO (Fig. 3 E-F).
Persistent gene expression of downstream targets of the Bmp-signaling such as
Msx gene in Bmp4 CKO embryos suggested that other Bmp ligands likely had
overlapping functions with Bmp4 in CNC.
To test this idea, we generated compound conditional loss of function
mutants for Bmp2, Bmp4, and Bmp7 using the Wnt1cre driver. Analysis of Bmp4
and Bmp7 compound mutants indicated that Bmp7 failed to have a significant
influence on Bmp4 CKO mutant phenotype (Fig. 4 A-E and 5 A). In contrast, Bmp2
deletion in the Bmp4 CKO background resulted in significant worsening of frontal
and mandibular bone phenotypes. The Bmp2/4 CKO mutant had a drastic reduction
in most CNC-derivates bones, such as the frontal and mandible (Fig. 4 F-I and 5 B).
16

Figure 3. Defects in osteoblast maturation in the absence of Bmp4.
Msx1 (A-B) and Msx2 (C-D) expression pattern in controls and Bmp4 CKO
embryos. Arrow denotes the expression of these genes in the frontal bone
primordium at E12.5. The Bmp4 CKO mutant has reduced expression of Msx1 (B)
and Msx2 (D) in the frontal bone primordium compared to control. (E-F) Alkaline
phosphatase staining of mature osteoblasts in control and Bmp4 CKO mutant at
E14.5. The Bmp4 CKO mutant frontal bone (arrow) is extremely reduced, though
the parietal bone (arrowhead) is normal when compare to control. f, frontal bone;
p, parietal bone.
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Figure 4.
mutants.

Increased severity of craniofacial defects in Bmp compounds

Alcian blue/alizarin red stains of E18.5 embryo showing defects in the frontal and
mandible bone. Arrow indicated the distance between the frontal bones use to
measure the frontal fontanelle for each genotype. a, angular process; av, alveolar
bone; c, coronoid process; co, condylar process; f, frontal bone; ff, frontal
fontanelle; n, nasal bone; p, parietal bone. * indicates a p-value < 0.05, error bars
represent SEM.
18

Figure 5. Bmp4 and Bmp2 are the major ligands in frontal bone development.
Bmp compounds mutants have an increase in the frontal fontanelle size when
compare to littermate wildtype.
19

Additionally, Bmp2 had a unique role in coronoid process development (Fig. 4 G, K,
N). Analysis of triple mutant combinations further supported the conclusion that
Bmp4 and Bmp2 were the major ligands in frontal and mandibular bone
development. Comparison between embryos that were Bmp2; Bmp4 compound
homozygous and were either Bmp7+/+, Bmp7flox/+ or Bmp7flox/flox indicated that Bmp7
has a minor role in frontal bone formation (Fig. 4 I, P and Q). In addition to the
frontal and mandibular bone defects, others CNC derivative bones were affected in
Bmp compound mutants (Table 1). This genetic analysis indicated that while Bmp4
was the major functional Bmp ligand in CNC-derived bone development Bmp2 also
had important functions.

Inducible over-expression of Bmp4 in the CNC
A bacterial based, tetracycline inducible system was used to control the
expression of Bmp4 in the cranial mesenchymal cells that give rise to the mandible
and most midfacial bones (Chai and Maxson, 2006).

It has been shown that with

this system the induction of tetracycline, or its analog doxycycline has low basal
activity, high levels of inducibility and low toxicity. In addition, multiple studies have
demonstrate that tetracycline and doxycycline cross the placenta, making this
system valuable for developmental studies (Gossen et al., 1995; Shin et al., 1999).
The tetracycline inducible system is a two-component system based on the E.
Coli tet repressor. Two versions of this system exist, the original tTA and a modified

20

Table 1. Bmp compounds mutant defects in the skeletal elements of the skull.
Bone defects severity was scored as follows: 0, no change; 1, size reduction; 2, missing pieces and 3, missing bone.
CP: cleft palate.

21

reverse Tet repressor, rtTA. In both systems, the tTA or rtTA fusion proteins are
expressed in the cell type of interest by a tissue specific regulatory element
(Gossen et al., 1995). We used a conditional reverse tetracycline transcriptional
activator allele generated at Dr. Andras Nagy laboratory (Mount Sinai Hospital,
Canada). The allele has an rtTA coding sequence incorporated into the Rosa 26
locus (Fig. 6 C). This allele is similar to the Rosa 26 reporter in that the rtTA is
expressed only after removal of the LoxP flanked cassette that is dependent on cre
recombinase activity (Belteki et al., 2005). In this system, rtTA protein binds to the
tetracycline operator in the presence of the tetracycline analog, doxycycline (Fig. 6
C). Upon binding to the tetracycline operator (TetO), the rtTA activates transcription
of the tetracycline responder transgene. This binding is not permanent and in the
absence of doxyclycline the transcription of the TetO responder gene stops.
To investigate the role of elevated Bmp4-signaling in CNC, we developed a
tetracycline-regulated Bmp4 allele (Bmp4TetO) by replacing the first non-coding exon
and basal promoter region of Bmp4 with a tet operator Bmp4 cDNA fusion gene
(Figure 6 A-B).

We used a cre-recombinase inducible rtTA (Tet-on) allele,

R26RrtTANagy allele, and the Wnt1cre allele to induce rtTA in the CNC lineage. Bmp4
was overexpressed by inducing Wnt1cre; Bmp4TetO; R26RrtTANagy (Bmp4 OE)
embryos with doxycycline (dox).
Next, we determined whether the Bmp4TetO allele directed significant levels of
Bmp4 expression in the CNC lineage. We treat the pregnant females with different
concentration of dox in the drinking water for 24 hours. We used mandible tissue of
Bmp4 OE embryos and compared them to littermate embryos that possessed two
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Figure 6. A tetracycline regulated Bmp4 gain of function allele.
(A) Targeting vector of Bmp4tetO allele, which contains the tetracycline operator
(tetO7), CMV basal promoter, Bmp4 cDNA, IRES-lacZ and PGK-neo resistance
cassette with two flanking Frt sites, targeted in Bmp4 basal promoter and Bmp4
exon1. (B) Clones were screened by Southern blot, showing correct targeting by a
Spe1 digestion: the wild type band was 6.4 kb, the cDNA band was 11.7 kb, and the
mutant allele was 8.0 kb. (C) Schematic illustrating the strategy to regulate spatial
and temporal expression of Bmp4 using the R26RrtTANagy allele (Belteki et al.,
2005).
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wild type copies of the Bmp4 allele (Wnt1cre; R26RrtTANagy) as the control tissue.
qRT-PCR analysis indicated that Bmp4 OE embryos had approximately 30-fold
inducible Bmp4 upregulation. Furthermore, Bmp4 levels were increased with higher
levels of dox (Figure 7 A). We select the higher inducible dose of 2 mg/ml of dox for
further experiments.

Next, we want to determine how quickly our system can

induce transcription of Bmp4Teto allele. Bmp4 induction could be detected by qRTPCR 3 hours after dox induction and remained elevated through 24 hours of
induction (Figure 7 B). Elevated Bmp4 was also detectable in CNC by whole mount
in situ in E10.5 embryos after 24 hours of induction (Figure 7 C). Western blot
indicated that the elevated Bmp4 mRNA expression resulted in about a 2.5-fold
increase in p-Smad1/5/8 activity in the mandibular process revealing that negative
regulatory mechanisms have a large impact on Bmp-signaling output (Figure 7 D).
Therefore, we have been able to show that with this system we can control the
spatial and temporal over-expression of Bmp4.

Facial form is dramatically altered by elevated Bmp4 in CNC.
We tested the phenotypic effects of elevated Bmp4 expression in the CNC by
analyzing E16.5 Bmp4 OE embryos that had been induced at different embryonic
stages. Bmp4 inductions starting at E13.5 caused a defect in the mandible
development. Mandibles were more pointed in appearance (Fig. 8 A-D), while this
phenotype was intensified in the early induction (Fig. 8 D, H and L). In addition to
the size reduction of the mandible, when induction started at E11.5, Bmp4 OE
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embryos showed open eyelids defects and a reduction in size of the whisker pad
region (Fig. 8 E-F). The most drastic change in facial appearance was observed in
Bmp4 OE induced at E10.5. Besides the open eyelid phenotype, there was a
shortening and pointed appearance in both the mandible and maxilla.

These

embryos show undifferentiated epithelium in which the whisker pad is not
recognizable (Fig. 8 I-J). The overall shape of the head was more rounded as
compared to control mouse embryo. Moreover, the orientation of the eyes was
more anterior as compared to the control (Fig. 8 D, H and L). Induction at early time
points resulted in open neural tube defects (data not shown).

These findings

indicate that increasing Bmp4 levels regulated facial form in a stage-dependent
fashion.
Skeletal preparations at E16.5 indicated that Bmp4 induction starting at
E10.5, resulted in strong reduction of rostral bony elements, such as nasal bones,
with a drastically shortened face (Fig. 9 G, H). Overall bone quality was defective as
revealed by multiple translucent areas in the skull bones. Bmp4 induction at E12.5
had a less dramatic morphologic change, but the size of the nasal cartilages was
expanded while nasal and frontal bones were absent or reduced (Fig. 9 E, F) and
the mandible was shorter. Induction at E13.5 revealed reduction in nasal bones
and coronoid process of the mandible (Fig. 9 C, D)
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Figure 7. Overexpression of Bmp4 using doxycycline regulated system.
(A) qRT-PCR of E11.5 mandibles showing the response of the Bmp4tetO allete to
different concentration of doxycycline. (B) qRT-PCR of E11.5 mandibles showing
the response of the Bmp4tetO allele to doxycycline at different periods of time. (C) In
situ hybridization showing total levels of Bmp4 transcript after 24 hrs of doxycycline
(2mg/ml). (D) Western blot and densitometry (n=3) analysis of E11.5 mandibles
after 24 hrs of doxycycline (2mg/ml), 10ug protein/lane. ** indicates a p-value <
0.01, *** indicates a p-value < 0.001, error bars represent SEM.
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Figure 8. Morphological changes in the craniofacial region after Bmp4 overexpression.
Frontal and lateral views of control and Bmp4 OE embryos after the indicated
induction period. Arrows point at the morphologies changes in the mandible.
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Figure 9. Defective cranial bone ossification in the Bmp4 OE embryos.
Lateral (A,C,E,G) and top (B,D,F,H) view of E16.5 control (A-B) and Bmp4 OE
embryos (C-H) after skeletal analysis. Bmp4 induction started at different time
points: E13.5 (C-D), E12.5 (E-F), and E10.5 (G-H). a, angular process; c, coronoid
process; co, condylar process; f, frontal bone; ip, interparietal bone; m, mandible;
mx, maxillary; n, nasal bone; p, parietal bone.
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Figure 10. Bmp4 OE embryos exhibit an expansion of the facial cartilage.
H&E staining of E16.5 control (A-D) and Bmp4 OE embryos induced at E14.5 (E-H)
and E12.5 (I-L). Meckel’s cartilage is expanded in the Bmp4 OE embryos. B, F and
J are magnified view of dashed box in A, E and I, respectively. The nasal cartilage
is also expanded in the Bmp4 OE embryos. D, H and J are magnified view of
dashed box in C, G and K, respectively. E, eye; I, incisor; MC, Meckel’s cartilage;
T, tongue. * indicate the cleft palate phenotype.
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Histologic analysis indicated that Bmp4 E12.5 induction resulted in a large
increase in both nasal and Meckel’s cartilage indicating that Bmp4 modulates facial
form by controlling both cartilage and bone development (Fig. 10 A-D, I-L). These
Bmp4 E12.5 induced embryos also had cleft palate (Fig. 10 K). Embryos induced at
E14.5 show milder phenotypes indicating that Bmp4 induced facial changes are
stage dependent (Fig. 10 E-H). These findings indicate that increasing Bmp4 levels
regulated facial form in a stage-dependent fashion.

Expression profiling uncovers transcriptional regulators that are upregulated
in the mandible of Bmp4 gain of function embryos.
To comprehensively investigate genes regulated by Bmp-signaling in the
mandibular process, we performed a microarray analysis. For this experiments, we
used RNA extracted from mandibles of Bmp4OE and Wnt1cre; R26RrtTANagy control
embryos that were induced with dox for 24 hours, starting at E10.5. Using a 2-fold
change (p< 0.05) as threshold, we identified 144 down-regulated and 120 upregulated genes (Fig. 11 A and Appendix 3). Gene ontology analysis for all genes
revealed several gene clusters involved in various cellular processes, such as
nucleic acid metabolism, cellular biosynthesis, regulation of gene expression and
transcription activity (Fig. 11 B). Strikingly, among genes that were up-regulated
after Bmp4 induction, gene ontology indicated that transcriptional regulation was the
main cellular process influenced by upregulated Bmp-signaling (Fig. 11 C and 12
A).
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Figure 11. Differentially expressed genes in Bmp4OE mandibles.
(A) Heat map showing 264 genes that were differentially expressed (>2-fold) in the
Bmp4OE mandibles; 120 were up-regulated (pink), while 144 were down-regulated
(blue). (B) Gene Ontology analysis of 264 differentially expressed genes. (C) Gene
Ontology analysis of up-regulated genes.
31

Figure 12. Bmp4 gain of function in the neural crest cells leads to upregulation of different transcriptional regulators.
(A) Heat map representing 16 transcriptional regulators that were upregulated in
Bmp4 OE mandibles (B) qRT-PCR validation of microarray results. Other genes
from the same family were also included. * indicates a p-value < 0.05, ** indicates a
p-value < 0.01, *** indicates a p-value < 0.001, error bars represent SEM.
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In order to confirm the microarray results, we used independently generated
RNA from control and Bmp4 OE mandibles, and subjected them to qRT-PCR
analysis. Included in the Bmp4 induced genes (BIG) signature after qRT-PCR
validation were multiple transcription factor families, including Gata genes, Hand
genes, Satb genes and Klf genes (Fig. 12 B). Other upregulated transcriptional
regulators include Atf3, Cux2, and Isl1. Gata2, Hand2 and Satb2 are transcription
factors that play important roles in craniofacial development (Barbosa et al., 2007;
Dobreva et al., 2006; Ruest et al., 2004b). Importantly, many of these genes (such
as Isl1 and Id1) have been shown to be targets of Smad-mediated signaling in other
developmental processes and many have known roles in craniofacial development
(Korchynskyi and ten Dijke, 2002; Mitsiadis et al., 2003).

Interestingly, known

negative regulators of Bmp-Smad signaling, Gadd45 and Smad6, and Noggin, were
also strongly upregulated in the Bmp4 OE mandibles uncovering a negative
feedback pathway in the mandible (Nohe et al., 2004; Suzuki et al., 2009).
We further validated the microarray experiments by in situ hybridization
analysis of the RNA transcripts. In situ hybridization demonstrated an expanded
expression pattern of the BIG signature after Bmp4 induction (Fig. 13 and 14).
Interestingly, there were distinct upregulated gene expression patterns. Some
genes, such as Hand1 and Smad6 were broadly expanded throughout the CNC
whereas other genes, such as Gadd45γ and Satb2, were expanded in a more
restricted region of the mandible (Fig. 13).
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Figure 13. Expanded expression pattern of the BIG signature after Bmp4
induction.
In situ hybridization on E11.5 embryos showing the change in the expression
pattern of the indicated genes in the Bmp4 OE.
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Figure 14. Expression patterns of up-regulated genes in Bmp4OE embryos.
In situ hybridization on E11.5 controls and Bmp4OE embryos, showing the change
in the expression pattern of the indicated genes.
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Figure 15. Bmp deficiency results in reduced mandibular expression of Bmpregulated genes. (A) qRT-PCR of E11.5 control and Nkx2.5cre;Bmp4 CKO
mandibles. (B) In situ hybridization on E11.5 embryos showing the change in the
expression pattern of the indicated genes in the Nkx2.5cre;Bmp4 CKO. * indicates a
p-value < 0.05, ** indicates a p-value < 0.01, *** indicates a p-value < 0.001, error
bars represent SEM.
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Common target genes that are expanded in the Bmp4 OE embryos are also
downregulated in Bmp loss of function embryos.
To determine whether the same sets of genes that are upregulated in the
Bmp4 OE embryos were also reduced in the Bmp loss of function embryos, we
evaluated the expression of the candidate genes in response to decreased BmpSmad activity. Because the Wnt1cre; Bmp2/4/7 triple mutants are recovered at low
frequencies, we supplemented our experiments with the Nkx2.5cre; Bmp4n/f embryos
that have greatly reduced Bmp-signaling in the mandibular ectoderm and
mesenchyme (Liu et al., 2005a). qRT-PCR analysis of the mandibular tissue
showed significant reduction in the expression levels of genes that were upregulated in the Bmp4 OE tissue (Fig. 15 A).

Moreover, whole mount in situ

analysis for a subset of these genes revealed loss of mandibular expression in
Bmp4 mutant embryos (Fig. 15 B).

Subsets of transcriptional regulators are direct Bmp4 targets.
The up-regulation of Gadd45γ, Gata3, Hand1, Satb2 and Smad6 transcripts
in a cell environment rich in Bmp4 signaling, as well as, their down-regulation in the
absence of Bmp4 (Fig. 13 and Fig. 15 B), give rise to the possibility that these
genes are direct targets of Bmp4 signaling.

To determine whether these BIG

signature genes were directly regulated by Smad-mediated transcription, we
undertook a bioinformatic approach to identify conserved Smad recognition
elements within a 5Kb region located in the 5’ flanking region of these genes. For
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Gadd45γ, Gata3, Hand1, Satb2 and Smad6, we uncovered phylogenetically
conserved Smad recognition elements (Fig. 16 A). We tested the ability of Smad1/5
to bind to these sequences in vivo by ChIP assays in wild-type mandibles and in the
mouse osteoblastic cell line, MC3T3-E1. Our data indicate that in the developing
mandible, Smad1/5 binds directly to the chromatin of these five genes (Fig. 16 B).
Moreover, in MC3T3-E1 cells that were cultured in the presence of Bmp4, we found
an increased enrichment in Smad1/5 chromatin binding after Bmp treatment (Fig.
16 C).
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Figure 16. Direct, Smad-mediated regulation of a subset of Bmp-induced
genes.
(A) Sequence alignment showing the conservation among species of the putative
Smad1 binding site. ChIP assay using (B) E11.5 wild-type mandibles and (C)
MC3T3-E1 cells culture for 12 hrs in the absent or presence of 25pg/ul of Bmp4.
(D) Bmp regulates craniofacial skeletal development by balancing self-renewal and
differentiation in the CNC progenitors
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Discussion
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We performed a comprehensive analysis of Bmp function in CNC using
genetics, gene expression profiling, and ChIP. Our profiling and qRT-PCR validation
data from the Bmp4 OE embryos indicate that the BIG signature contains twentyone genes. Moreover, we validated seventeen of the twenty-one genes in the Bmp
loss of function model revealing that Bmp is necessary and sufficient for expression
of those seventeen genes.
Our data reveal that Bmp controls bone morphogenesis and facial form via
common target genes. The BIG signature was upregulated in Bmp4 OE embryos
with facial form changes and reduced in Bmp deficient embryos with severe bone
morphogenesis phenotypes. Within the BIG signature are transcriptional regulators
important for osteoblast differentiation and progenitor cell self-renewal. Bmpsignaling also induces a negative regulatory pathway that likely functions as a
buffering mechanism to maintain precise Bmp-signaling levels. We show that six
genes, Gata3, Gadd45γ, Hand1, Satb2, and Smad6, are directly bound by Smad
1/5. Our findings indicate that a balance between self-renewal and progenitor
differentiation in CNC underlies Bmp-regulated facial form control and bone
morphogenesis (Figure 16 D).

Direct Bmp target genes regulate cranial neural crest progenitor selfrenewal.
Our data show that Bmp-signaling in CNC progenitors regulates genes that
are directly implicated in self-renewal such as Id and Klf genes. Klf2 and Klf5, as
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well as Id1 and Id4 are regulated by Bmp-signaling in CNC progenitors. Klf genes,
regulators of ES cell self-renewal by controlling Nanog expression and cellular
reprogramming, have not been shown to be regulated by Bmp-signaling (Zhang et
al., 2010). Our findings suggest that Bmp-signaling in CNC promotes limited selfrenewal of CNC cells that allow progenitor cells to persist for a short time as
craniofacial development progresses.
In other in vivo model systems, such as the Drosophila ovary, Bmp signaling
promotes self-renewal and proliferation of somatic stem cells and prolongs
progenitor lifespan (Kirilly et al., 2005). In CNC progenitors, it is conceivable that
Bmp-signaling increases the number of self-renewing progenitor cells in addition to
activating expression of the CNC self-renewal program.
In addition to inducing Id1 expression in embryonic stem cells, Bmp-signaling
directly promotes self-renewal in collaboration with leukemia inhibitory factor
through a direct interaction between Smad1 and the core self-renewal factors
Nanog, Oct4 and Sox2 (Chen et al., 2008; Fei et al., 2010; Ying et al., 2003). As
defined by ChIP seq, Smad1 commonly occupies Nanog-Oct4-Sox2 bound loci
revealing that Bmp-signaling directly interacts with the core pluripotency machinery
to enhance pluripotency and self-renewal. Moreover, the Smad1-containing
complexes in ES cells recruit the HAT p300 to activate gene transcription (Chen et
al., 2008). Our findings support a model in which Bmp-signaling enhances CNC
progenitor self-renewal by activating the self-renewal gene program. Future ChIP
seq experiments will be required to determine if Smad1 directly interacts with a
pluripotency program in CNC progenitors.
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Bmp promotes osteoblast differentiation from CNC progenitors.
Bmp-signaling also regulates lineage-restricted genes such as Satb2 that
enhance osteoblast lineage development. Satb2 is a DNA binding and architectural
factor that has a positive role in osteoblast development. Satb2 deficiency results in
phenotypes that are similar to mild Bmp loss of function phenotypes such as cleft
palate and calvarial defects with shortened mandible. Importantly, Satb2 controls
osteoblast differentiation through regulation of Runx2 and Atf4 expression (Dobreva
et al., 2006). Notably, similar to Bmp4, Satb2 deficiency causes orofacial clefting in
humans as well as mice (Britanova et al., 2006). Our data shows that Satb2 is a
direct Smad1/5 target indicating that a major pathway for Bmp-regulated bone
development and facial form regulation is through Satb2 function.
Similar to Bmp4 loss of function mutants, Gata3 mutants have a medial
mandibular deficiency (Liu et al., 2005a; Ruest et al., 2004a). There is evidence that
Gata3 directly regulates N-myc in the branchial arches suggesting that one cellular
mechanism in the Gata3 mutant mandible is reduced proliferation (Potvin et al.,
2010). Other data also indicate that Gata3 promotes osteoblast and neuron survival
suggesting that in addition to proliferation, apoptosis may also be enhanced in
Gata3 mutants as it is in Bmp4 loss of function embryos (Chen et al., 2010; Liu et
al., 2005a; Tsarovina et al., 2010).
Hand1

and

Hand2 have

overlapping function

in

medial mandible

development, and promote progenitor cell proliferation and inhibit differentiation
(Barbosa et al., 2007; Funato et al., 2009). In the heart, Hand1 overexpression
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increases cell proliferation indicating that the Hand mandibular defect may result
from reduced progenitor cell proliferation. It is interesting to note that both Hand1
and Gata3 have been implicated in trophoblast development indicating that these
two genes may have interrelated functions in multiple cellular contexts (Ralston et
al., 2010).
In addition to Bmp-signaling, the Endothelin (Edn) signaling pathway
regulates Hand gene expression and also is critically important in facial form
regulation. Edn deficient embryos display mandibular to maxillary transformations
that are restricted to the Hox negative CNC (Gitton et al., 2010). Moreover, gain of
function experiments indicate that expanded Edn and Hand2 in maxillary process
results in transformation to a mandibular phenotype. Our data indicate that Bmp and
Edn-signaling converge on Hand gene function to regulate facial form.
The Dlx 5/6 genes, targets for Edn-signaling and direct regulators of Hand2,
are also critically important in facial form development (Depew et al., 2002). Only
modest Dlx6 expansion in Bmp4 OE embryos indicate that Bmp induced regulation
of Hand genes primarily goes directly through Smad 1/5 (Fig. 14).

Bmp-regulated negative feedback loops are critical for mandible development
Negative auto-regulation is a mechanism to confer robustness to the
developing embryo by buffering the system from elevated Bmp levels and is critical
for normal craniofacial and heart development (Paulsen et al., 2011; Prall et al.,
2007). Bmp4 induced expression of genes that are negative regulators of Bmp45

signaling such as Smad6, Noggin, and Gadd45. The importance of finely tuned
Bmp-signaling levels in mice and humans is apparent from Noggin loss of function
studies in mice as well as human genetics studies. Noggin deficiency results in cleft
palate, defective mandibular development, as well as limb and heart defects (Brunet
et al., 1998; Choi et al., 2007; Gong et al., 1999; He et al., 2010). The negative
auto-regulatory pathway includes two genes, Gadd45γ and Smad6 that are Smadregulated direct Bmp targets. Moreover, the negative auto-regulatory pathway
modulates the pathway by multiple mechanisms. Smad6 inhibits R-Smad activity by
both competing for Smad4 and also inhibiting R-Smad phosphorylation. Gadd45γ
promotes ubiquitin ligase interaction with the Smad linker region to destabilize RSmad, while Noggin is a competitive inhibitor of the Bmp ligand-receptor interaction
(Sheng et al., 2010).

Bmp-signaling controls expression of multiple families of transcriptional
regulators
Cux2 has not been previously connected to Bmp-signaling or bone
morphogenesis. The closely related gene, Cux1, is regulated by Tgf-β and
represses collagen expression. Cux2 is regulated by Notch in the spinal cord where
it controls cell cycle progression and promotes interneuron fate. Cux2 also has
been shown to regulate dendrite morphology in post-natal brain (Iulianella et al.,
2009; Iulianella et al., 2003).
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Among the other Bmp-regulated genes that we identified, are genes that
were previously shown to be Bmp-regulated. Previous experiments uncovered a
Bmp-Msx genetic pathway in multiple contexts within the developing craniofacial
apparatus including skull, palate and teeth (Chai and Maxson, 2006). Our data also
indicate that Isl1 is regulated by Bmp-signaling during mandibular development.
There is evidence that Bmp and Isl1 function in a positive feedback loop in the
mandible (Mitsiadis et al., 2003). Our data support these earlier findings and
substantially extend previous understanding of Bmp targets in craniofacial
development.

Future direction
Our in situ data indicate that in the Bmp4 OE embryos one gene group
including Gata3, Hand1, and Smad6 was broadly expressed throughout the cranial
neural crest in response to Bmp4 overexpression. In contrast, genes such as Satb2
and Gadd45γ were more resistant to Bmp4 overexpression and were upregulated in
a more discrete spatial pattern. This observation exposes the possibility of other
regulatory mechanisms capable of fine-tune the expression of Satb2 and Gadd45γ.
miRNA are small non-coding RNAs that post transcriptionally regulate gene
expression by enhancing mRNA degradation or by inhibiting translation (Bartel,
2009). Recently studies show the participation of Bmp induced Smad signaling
activity during the transcription of microRNA (miRNA).

It has been revealed

capability of Smad1/5 to directly bind to the Drosha complex to promote microRNA
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(miR) processing (Davis et al., 2008). Furthermore, our group has shown that Bmpsignaling can induce miR transcription through a canonical Smad regulated
mechanism (Wang et al., 2010).
To test the possible involving of miRNA in the Bmp4 OE embryos
phenotypes, we can simultaneous induce heterozygosity of Dicer in the Bmp4 OE
embryos (Wnt1cre; Bmp4teto; R26Nagy+/-; Dicerf/+). If the elevated levels of Bmp4
observed in the Bmp4 OE embryos are triggering a miRNA activation pathway,
heterozygosity of Dicer should suppress some of the phenotype observed in the
Bmp4 OE embryos.
One idea is that other signaling pathways, such as Wnts, may regulate miR
expression that then degrades target mRNAs in certain domains of the branchial
arches. Alternatively, the distinct responses to Bmp4 signaling may be regulated at
the level of chromatin regulation such that Smad mediated activation is offset by
negative regulatory mechanisms that cannot be overcome by high levels of Bmpsignaling.
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Appendix
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Appendix 1. Bmp2, Bmp4, and Bmp7 conditional null alleles.
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Appendix 2. Primers sequence for qRT-PCR and ChIP experiments.
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Appendix 3. List of statistically significant genes that were differentially
expressed in the mandible after Bmp4 over-expression.

probe id
mMC004687
mMC004895
mMC007461
mMC001824

Bmp4 OE vs
Control
(FoldChange)
-13.1
-12.75
-8.88
-7.55

Bmp4 OE vs
Control (Pvalue)
0.0004
0.0021
0.0002
0.0017

Ensembl
Gene
Symbol
Cbln4
Osr2
Barx1
Shox2

mMC006410

-7.53

0.0026

Smoc1

mMC011279
mMC013934
mMR028474
mMC018294
mMR028929
mMC001020
mMC002854
mMC023938
mMC005050
mMC004704
mMC017469
mMC024318
mMC001087
mMC006133
mMC012585
mMC023854
mMC011362
mMR028699
mMC020668
mMC010520
mMC006582
mMR026812
mMC011387
mMC004686
mMR027206
mMC014693
mMC012271
mMC015778
mMC009536
mMC009633
mMC007876
mMC005287
mMC020953
mMC004112
mMC011604
mMC012120
mMC016088
mMC016113
mMC024238
mMC011610
mMC019146

-7.26
-7.25
-6.55
-6.15
-5.25
-5.1
-4.87
-4.72
-4.66
-4.42
-4.26
-4.23
-4.18
-4.08
-4.08
-4
-3.95
-3.89
-3.78
-3.75
-3.73
-3.61
-3.6
-3.57
-3.44
-3.32
-3.27
-3.12
-3.09
-3.07
-3.06
-3.01
-3
-3
-2.99
-2.99
-2.92
-2.88
-2.87
-2.87
-2.84

0.0023
0.0032
0.0029
0.0016
0.0017
0.0093
0.0004
0.0132
0.0006
0.0031
0.0035
0.0004
0.006
0.0041
0.0026
0.026
0.0004
0.0152
0.0002
0.0011
0.0013
0.0178
0.0009
0.0017
0.0008
0.0079
0.0028
0.0075
0.0041
0.0065
0.0029
0.0032
0.0048
0.0043
0.0068
0.0003
0.0044
0.0048
0.0006
9.35E-05
0.0079

Smoc2
Meox2
Cyp1b1
Bnc1
Tbx15
Osr1
Crlf1
Pax1
Prr6
Wnt2
Dkk4
Angptl1
Has2
Aldh1a2
Cyp26a1
Eya4
Sfrp2
Birc5
Tgfbr3
Prdx2
Thy1
Cdk5r1
Tbc1d2
Irx2
Spp1
Bnc2
Col8a1
Mkx
Adora2b
Pax3
Ddit4l
Etv5
Sfrp1
Mmd2
Twist2
Ccne1
Hey2
Emx2
Hoxd8
Lingo2
Tnc

Ensembl Gene Description
Cerebellin-4 precursor.
Protein odd-skipped-related 2.
Homeobox protein BarH-like 1.
Short stature homeobox protein 2.
SPARC-related modular calcium-binding protein 1
precursor
SPARC-related modular calcium-binding protein 2
precursor
Homeobox protein MOX-2.
Cytochrome P450 1B1.
Zinc finger protein basonuclin-1.
T-box transcription factor TBX15.
Protein odd-skipped-related 1.
Cytokine receptor-like factor 1 precursor.
Paired box protein Pax-1.
Proline-rich protein 6.
Protein Wnt-2 precursor.
Dickkopf-related protein 4 precursor.
Angiopoietin-related protein 1 precursor.
Hyaluronan synthase 2.
Retinal dehydrogenase 2.
Cytochrome P450 26A1.
Eyes absent homolog 4.
Secreted frizzled-related protein 2 precursor.
Baculoviral IAP repeat-containing protein 5.
TGF-beta receptor type III precursor.
Peroxiredoxin-2.
Thy-1 membrane glycoprotein precursor.
Cyclin-dependent kinase 5 activator 1 precursor.
TBC1 domain family, member 2.
Iroquois-class homeodomain protein IRX-2.
Osteopontin precursor (Bone sialoprotein 1)
Zinc finger protein basonuclin-2.
Collagen alpha-1(VIII) chain precursor.
Homeobox protein Mohawk.
Adenosine receptor A2b.
Paired box protein Pax-3.
DNA-damage-inducible transcript 4-like protein.
ETS translocation variant 5.
Secreted frizzled-related protein 1 precursor (sFRP-1).
Monocyte to macrophage differentiation factor 2.
Twist-related protein 2 (Dermo-1).
G1/S-specific cyclin-E1.
Hairy and enhancer of split-related protein 2.
Homeobox protein EMX2 (Empty spiracles homolog 2).
Homeobox protein Hox-D8 (Hox-4.3) (Hox-5.4).
leucine rich repeat and Ig domain containing 2.
Tenascin precursor (TN) (Tenascin-C).
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mMR027081

-2.84

0.0011

Jarid1d

probe id
mMC005059
mMC014576
mMC011224
mMC016964
mMR029106
mMC025853
mMC007337
mMC006073
mMR027782
mMC007882
mMC013088
mMC021257
mMR027630
mMR027330
mMC023785
mMC015557
mMC011218
mMC005685
mMC004336
mMC020644
mMC002917
mMR029325
mMC024692
mMR030518
mMC010000
mMR026292
mMC021250
mMC016640
mMC016646
mMC009648

Bmp4 OE vs
Control
(FoldChange)
-2.81
-2.78
-2.76
-2.76
-2.76
-2.75
-2.72
-2.63
-2.63
-2.6
-2.58
-2.57
-2.56
-2.55
-2.54
-2.53
-2.52
-2.51
-2.51
-2.5
-2.5
-2.48
-2.47
-2.46
-2.46
-2.43
-2.42
-2.4
-2.39
-2.39

Bmp4 OE vs
Control (Pvalue)
0.0046
0.0043
0.0003
0.0005
1.90E-05
0.0072
0.0151
0.0047
0.0014
0.0025
0.0091
0.0104
0.0019
0.0194
0.0083
0.0007
0.0004
0.0019
0.0115
0.0131
0.0033
0.0016
0.0031
0.002
0.0028
0.0107
0.0051
0.0388
0.0067
0.0006

Ensembl
Gene
Symbol
Kif4
Agtr1a
Lhx8
Mxd3
Tbx18
Col23a1
Acadm
Nt5e
Tcfap2c
Phf17
Calca
Bub1
Ccnd1
Fgf10
Lhx9
Col27a1
Fanci
Dlx1
Recql4
Bok
Epha3
Col6a3
Ccnd1
Ddx3y
Wnt9a
Nfatc1
Pitx1
Pola1
Egfr
Bmp7

mMC013663
mMC003890
mMC008043
mMC004121
mMR029934
mMR029574
mMC002759
mMC010318
mMC008299
mMC019230
mMC005043
mMR027407
mMC004631
mMC025368

-2.39
-2.38
-2.37
-2.36
-2.35
-2.33
-2.31
-2.31
-2.31
-2.29
-2.29
-2.28
-2.27
-2.27

0.0118
0.0064
0.0204
0.0066
0.0017
0.0004
0.027
0.0165
0.0111
0.0291
0.0052
0.0203
0.0059
0.0022

Tnmd
Crabp2
Chek1
Spc24
Cdc6
Bmpr1b
Rad51
Foxd1
Efemp1
Tbx15
Twist1
Ddx3y
Lmcd1
Cdc20

Histone demethylase JARID1D.

Ensembl Gene Description
Chromosome-associated kinesin KIF4 (Chromokinesin).
Type-1A angiotensin II receptor (AT1) (AT1A).
LIM/homeobox protein Lhx8.
Max-interacting transcriptional repressor MAD3.
T-box transcription factor TBX18 (T-box protein 18).
Collagen alpha-1(XXIII) chain.
Medium-chain specific acyl-CoA dehydrogenase.
5'-nucleotidase precursor.
Transcription factor AP-2 gamma (AP2-gamma).
Protein Jade-1 (PHD finger protein 17).
Calcitonin gene-related peptide 1 precursor.
Mitotic checkpoint serine/threonine-protein kinase BUB1 .
G1/S-specific cyclin-D1.
Fibroblast growth factor 10 precursor.
LIM/homeobox protein Lhx9.
Collagen alpha-1(XXVII) chain precursor.
Fanconi anemia group I protein homolog.
Homeobox protein DLX-1.
ATP-dependent DNA helicase Q4.
Bcl-2-related ovarian killer protein (Matador protein).
Ephrin type-A receptor 3 precursor.
Collagen alpha3(VI) precursor (Fragment).
G1/S-specific cyclin-D1.
ATP-dependent RNA helicase DDX3Y.
Protein Wnt-9a precursor (Wnt-14).
Nuclear factor of activated T-cells, cytoplasmic 1.
Pituitary homeobox 1 (Homeobox protein P-OTX).
DNA polymerase alpha catalytic subunit.
Epidermal growth factor receptor precursor.
Bone morphogenetic protein 7 precursor.
Tenomodulin (TeM) (mTeM) (Chondromodulin-I-like
protein).
Cellular retinoic acid-binding protein 2.
Serine/threonine-protein kinase Chk1.
Kinetochore protein Spc24.
Cell division control protein 6 homolog.
Bone morphogenetic protein receptor type IB precursor.
DNA repair protein RAD51 homolog 1.
Forkhead box protein D1.
EGF-containing fibulin-like extracellular matrix protein 1.
T-box transcription factor TBX15.
Twist-related protein 1 (M-twist).
ATP-dependent RNA helicase DDX3Y.
LIM and cysteine-rich domains protein 1.
Cell division cycle protein 20 homolog.
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mMC023569
mMR028442
mMC022184
mMR028305

-2.26
-2.26
-2.26
-2.24

0.0074
0.0331
0.0013
0.0155

Cdc6
Dtl
Gtse1
Lhx8

probe id
mMC018720
mMC020210
mMC010627
mMC018217
mMC006090
mMC003963
mMC010387
mMC006225
mMC022453
mMC012277
mMC006899
mMR029214
mMC022196
mMC014446
mMC006074
mMC014443
mMR028076
mMC016874
mMC012062
mMC009891
mMC017517
mMC009710
mMC014769
mMC007490
mMC003317
mMR030048

Bmp4 OE vs
Control
(FoldChange)
-2.24
-2.23
-2.22
-2.22
-2.22
-2.21
-2.2
-2.2
-2.19
-2.19
-2.18
-2.18
-2.18
-2.17
-2.16
-2.15
-2.15
-2.14
-2.14
-2.13
-2.13
-2.13
-2.13
-2.11
-2.11
-2.11

Bmp4 OE vs
Control (Pvalue)
0.0006
0.0025
0.0124
0.0063
0.0319
0.0163
0.025
0.0012
0.0265
0.0462
0.0384
0.0297
0.0039
0.043
0.0034
0.0033
0.007
0.0018
0.0075
0.0012
0.0049
0.035
0.0117
0.0023
0.0287
0.008

Ensembl
Gene
Symbol
Eya2
Spon1
Gbx2
Cenpn
Wbp11
Fap
Spry2
Aurka
Fgf10
Mns1
Brca1
Smc2
Col23a1
Incenp
Xrcc3
Cdc25c
Barx2
Sgol2
Hist1h2ao
Spc25
Mlf1
Bard1
Rarb
Dcp2
Ercc6l
Wnt5a

mMC006771
mMC007743
mMC014831
mMR026709
mMC017313
mMR028181
mMC002529
mMC011122
mMC022135
mMC017102
mMC022855
mMC014639
mMC005065
mMC004902
mMR029647

-2.11
-2.11
-2.1
-2.1
-2.1
-2.09
-2.08
-2.08
-2.08
-2.07
-2.07
-2.05
-2.05
-2.05
-2.03

0.0115
0.0096
0.0026
0.0277
0.0317
0.0002
0.0265
0.0339
0.0012
0.0205
0.0006
0.0099
0.0194
0.0254
0.0053

Eml3
Ccnb2
Hist1h1b
Mbnl3
Gas2
Timp3
Bcl2
Cebpz
Plk1
Cdca2
Ccnb1
Pold2
Rbm8a
Pif1
Lix1

mMR027721
mMR028184

-2.03
-2.03

0.0234
0.0047

Col8a2
Gas2

mMC016105

-2.03

0.0381

Six2

Cell division control protein 6 homolog.
Denticleless protein homolog.
G2 and S phase-expressed protein 1.
LIM/homeobox protein Lhx8.

Ensembl Gene Description
Eyes absent homolog 2.
Spondin-1 precursor (F-spondin).
Gastrulation and brain-specific homeobox protein 2.
Centromere protein N (CENP-N).
WW domain-binding protein 11 (WBP-11).
Seprase (Fibroblast activation protein alpha).
Protein sprouty homolog 2.
Serine/threonine-protein kinase 6 (Aurora kinase A).
Fibroblast growth factor 10 precursor.
Meiosis-specific nuclear structural protein 1.
Breast cancer type 1 susceptibility protein homolog.
Structural maintenance of chromosomes protein 2.
Collagen alpha-1(XXIII) chain.
Inner centromere protein.
X-ray repair cross-complementing protein 3.
M-phase inducer phosphatase 3.
Homeobox protein BarH-like 2.
Shugoshin-like 2.
Histone H2A type 1.
Kinetochore protein Spc25.
Myeloid leukemia factor 1 .
BRCA1-associated RING domain protein 1 (BARD-1).
Retinoic acid receptor beta (RAR-beta).
mRNA-decapping enzyme 2.
excision repair cross-complementing group 6 - like.
Protein Wnt-5a precursor.
Echinoderm microtubule-associated protein-like 3
(EMAP-3).
G2/mitotic-specific cyclin-B2.
Histone H1.5 (H1 VAR.5) (H1b).
Muscleblind-like X-linked protein 3.
Growth arrest-specific protein 2.
Metalloproteinase inhibitor 3 precursor.
Apoptosis regulator Bcl-2.
CCAAT/enhancer-binding protein zeta.
Serine/threonine-protein kinase PLK1.
Cell division cycle-associated protein 2.
G2/mitotic-specific cyclin-B1.
DNA polymerase subunit delta-2.
RNA-binding protein 8A.
ATP-dependent DNA helicase PIF1.
Protein limb expression 1 homolog.
Collagen alpha-2(VIII) chain precursor, Endothelial
collagen.
Growth arrest-specific protein 2 (GAS-2).
Homeobox protein SIX2 (Sine oculis homeobox homolog
2).
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mMC018871
mMC005713
mMR026745
mMC001743
mMC026007

-2.01
-2.01
-2.01
-2
-2

0.0042
0.0377
0.0026
0.0044
0.0099

Cenpm
Cenpf
Tcfap2b
Has3
Suv39h2

probe id
mMR030652
mMC025149
mMC007940
mMC016067
mMC014229
mMC011307
mMC021817
mMC014455
mMC024996
mMC004022

Bmp4 OE vs
Control
(FoldChange)
2
2.01
2.01
2.02
2.03
2.05
2.05
2.05
2.06
2.06

Bmp4 OE vs
Control (Pvalue)
0.0194
0.0474
0.0002
0.0183
0.0083
0.0235
0.0149
0.0223
0.0208
0.0174

Gene
Symbol
Socs2
Olfr282
Msx1
Smyd1
Meis2
Mafb
Il18
Hao3
Ehmt1
Med17

mMC012216
mMC008429
mMC017691
mMC006701
mMC004293
mMC018176
mMR030084
mMC024704
mMC006134
mMC004625
mMR029458
mMC018508
mMC006059
mMR027435
mMC012387
mMR030613
mMC018518
mMC005104

2.07
2.08
2.09
2.09
2.09
2.1
2.1
2.11
2.12
2.12
2.13
2.13
2.13
2.13
2.13
2.14
2.14
2.15

0.0058
0.002
0.0123
0.0489
0.0103
0.0476
0.0053
0.0171
0.0389
0.0033
0.0141
0.0469
0.024
0.0047
0.0129
0.0234
0.042
0.0051

Gpr50
Guca1b
Tle2
Olfr552
Adh1
Art2b
Igfbp5
Olfr1102
Isl2
Gpr19
Tgfb1i1
Taok3
Spink5
Col24a1
Tle6
Gria2
Gprc5d
Sox5

mMC001008
mMC012578
mMC018772
mMC022310
mMC025035
mMC002788
mMR028041
mMC007974
mMC025800
mMC003788
mMC008313
mMR030964

2.16
2.16
2.17
2.19
2.19
2.21
2.22
2.23
2.24
2.24
2.24
2.24

0.0215
0.0219
0.0002
0.0265
0.0133
0.025
0.0089
0.0252
0.0004
0.0036
0.0275
0.0286

Efna1
Hspa2
Gprin3
Pafah1b2
Elmo1
Msr2
Serf1
Spsb1
Unc13b
Prrx2
Map3k1
Ptgs2

Centromere protein M.
centromere protein F.
Transcription factor AP-2 beta.
Hyaluronan synthase 3.
Histone-lysine N-methyltransferase SUV39H2.

Ensembl_Gene_Description
Suppressor of cytokine signaling 2.
olfactory receptor 282.
Homeobox protein MSX-1 (Msh homeobox 1-like protein).
SET and MYND domain-containing protein 1.
Homeobox protein Meis2 (Meis1-related protein 1).
Transcription factor MafB.
Interleukin-18 precursor.
Hydroxyacid oxidase 2.
euchromatic histone methyltransferase 1 isoform 1 .
Mediator of RNA polymerase II transcription subunit 17.
Melatonin-related receptor (G protein-coupled receptor
50).
Guanylate cyclase activator 1B.
Transducin-like enhancer protein 2.
olfactory receptor 552.
Alcohol dehydrogenase 1.
T-cell ecto-ADP-ribosyltransferase 2 precursor.
Insulin-like growth factor-binding protein 5 precursor.
Olfactory receptor 1102.
Insulin gene enhancer protein ISL-2 (Islet-2).
Probable G-protein coupled receptor 19.
Transforming growth factor beta-1-induced transcript 1.
Serine/threonine-protein kinase TAO3.
serine peptidase inhibitor, Kazal type 5.
procollagen, type XXIV, alpha 1.
Transducin-like enhancer protein 6.
Glutamate receptor 2 precursor.
G-protein coupled receptor family C group 5 member D.
Transcription factor SOX-5.
Ephrin-A1 (EPH-related receptor tyrosine kinase ligand
1).
Heat shock-related 70 kDa protein 2.
G protein-regulated inducer of neurite outgrowth 3.
Platelet-activating factor acetylhydrolase IB subunit beta.
Engulfment and cell motility protein 1 (CED-12 homolog).
macrophage scavenger receptor 2.
Small EDRK-rich factor 1 (4F5) (m4F5).
SPRY domain-containing SOCS box protein 1 (SSB-1).
Protein unc-13 homolog B (Munc13-2).
Paired mesoderm homeobox protein 2.
Mitogen-activated protein kinase kinase kinase 1.
Prostaglandin G/H synthase 2 precursor.
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probe id
mMC019189
mMR028863
mMC018573
mMR030035
mMC013645
mMC023971
mMC007194
mMC004741
mMC009330
mMC007674
mMC021286
mMC020398
mMC006869
mMR029558
mMC019522
mMC014141
mMR031232
mMC000927
mMC004037
mMC010754
mMR027525
mMC025342
mMC014959
mMR030256
mMC023884
mMC011878
mMC002262
mMC004603
mMR029853
mMC015376
mMC025896
mMC008166
mMC012597
mMC018691
mMC004630
mMC015898
mMC001101
mMC009367
mMC007158

Bmp4 OE vs
Control
(FoldChange)
2.25
2.25
2.26
2.26
2.26
2.28
2.3
2.31
2.31
2.32
2.34
2.34
2.36
2.39
2.44
2.44
2.44
2.45
2.46
2.46
2.48
2.48
2.49
2.5
2.53
2.53
2.53
2.55
2.59
2.6
2.6
2.61
2.62
2.62
2.64
2.64
2.65
2.65
2.66

Bmp4 OE vs
Control (Pvalue)
0.0051
0.0015
0.0378
0.0096
0.0033
0.0203
0.0177
0.0033
0.0366
0.0198
0.0188
0.0064
0.0315
0.0045
0.0356
0.0378
0.001
0.0395
0.003
0.0229
0.0067
0.0176
0.0257
0.0119
0.0392
0.0329
0.0203
0.0216
0.0046
0.0122
0.0032
0.0101
0.0461
0.0008
0.0006
0.0002
0.0266
0.0019
0.0021

Gene
Symbol
Olfr459
Klf5
Olfr411
Satb1
Alcam
Pmp22
Cd1d1
Skil
Olfr651
Mypn
Actg1
Krt8
Spon2
Rgs2
Shroom1
Olfr123
Cux2
Derl1
Angpt2
Abca1
Bmf
Syp
Id1
Evi1
Icos
Nrtn
Tnnt1
Pdlim3
Sox5
Lgals3
Dbx1
Olfr740
Nfkbia
Dck
Yipf2
Dkk1
Plac8
Atf3
Zfpm2

Ensembl_Gene_Description
olfactory receptor 459.
Krueppel-like factor 5.
olfactory receptor 411.
Special AT-rich sequence-binding protein 1.
CD166 antigen precursor.
Peripheral myelin protein 22.
T-cell surface glycoprotein CD1d1 precursor.
Ski-like protein.
olfactory receptor 651.
Myopalladin.
Actin, cytoplasmic 2 (Gamma-actin).
Keratin, type II cytoskeletal 8.
Spondin-2 precursor (Mindin).
Regulator of G-protein signaling 2 (RGS2).
Protein Shroom1.
olfactory receptor 123.
Homeobox protein cut-like 2.
Degradation in endoplasmic reticulum protein 1.
Angiopoietin-2 precursor.
ATP-binding cassette sub-family A member 1.
Bcl-2-modifying factor.
Synaptophysin (Major synaptic vesicle protein p38).
DNA-binding protein inhibitor, Inhibitor of DNA binding 1.
Ecotropic virus integration site 1 protein.
Inducible T-cell co-stimulator precursor.
Neurturin precursor.
Troponin T, slow skeletal muscle.
PDZ and LIM domain protein 3.
Transcription factor SOX-5.
Galectin-3 (Galactose-specific lectin 3).
Developing brain homeobox protein 1.
olfactory receptor 740
NF-kappa-B inhibitor alpha (I-kappa-B-alpha).
Deoxycytidine kinase.
Protein YIPF2 (YIP1 family member 2).
Dickkopf-related protein 1 precursor.
Placenta-specific gene 8 protein.
Cyclic AMP-dependent transcription factor ATF-3.
Zinc finger protein ZFPM2 (Friend of GATA protein 2).
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probe id
mMC001049
mMC018723
mMR030076
mMC012911
mMC008743
mMC002022
mMC004722
mMC005384
mMC021603
mMC013726
mMC004723
mMC006543
mMC006067
mMC012563
mMC011946
mMC008354
mMC006928
mMC007645
mMC019148
mMC007751
mMC011983
mMR028115
mMR029269
mMC002384
mMC005244
mMC009186
mMC023939
mMC011282
mMC012619
mMC008700
mMC008103
mMC020041
mMC005675
mMR029110
mMC013000
mMC002592
mMC008257
mMC013455
mMC017480
mMC021077
mMC007167

Bmp4 OE vs
Control
(FoldChange)
2.7
2.77
2.84
2.91
2.94
2.96
2.97
3.06
3.06
3.16
3.21
3.24
3.31
3.32
3.51
3.59
3.63
3.71
3.75
3.84
3.9
3.91
4.04
4.15
4.24
4.26
4.43
4.46
4.59
5.25
5.42
5.53
5.58
5.63
6.25
7.32
7.74
7.89
9.68
12.47
12.97

Bmp4 OE vs
Control (Pvalue)
0.0047
0.004
0.0063
0.0019
0.0169
0.0046
0.0173
0.0204
0.0056
0.0165
0.0015
0.0072
0.0028
0.0038
0.0272
0.0032
0.0306
0.001
0.0028
0.0002
0.0108
0.0027
0.0007
0.0022
0.0053
0.0034
0.0019
0.0053
0.0052
0.0003
0.0002
0.0022
0.01
0.0005
0.0026
0.0017
0.0013
6.84E-05
0.0003
0.0031
6.69E-05

Gene
Symbol
Thbs3
Epyc
Klf3
Sox5
Olfr1428
Vsx1
Olfr1423
Sepp1
Fgf22
Nkx2-6
Kap
Olfr571
Msx2
Gadd45g
Eid1
Sox8
Actrt1
Bmf
Col9a2
Hand1
Odf1
Ntng1
Col9a1
Gadd45b
S100a8
Tbx20
Gata6
Fbxo2
Nog
Smad6
Col9a3
Unc5b
Angpt1
Pdgfrl
Gata2
Igfbp7
Rgs5
Isl1
Bmp4
Gata3
Sct

Ensembl_Gene_Description
Thrombospondin-3 precursor.
Epiphycan precursor (Dermatan sulfate proteoglycan 3).
Krueppel-like factor 3.
Transcription factor SOX-5.
olfactory receptor 1428.
Visual system homeobox 1.
olfactory receptor 1423.
Selenoprotein P precursor.
Fibroblast growth factor 22 precursor.
Homeobox protein Nkx-2.6.
Kidney androgen-regulated protein precursor.
olfactory receptor 571.
Homeobox protein MSX-2 (Hox-8.1).
Growth arrest and DNA-damage-inducible protein.
EP300-interacting inhibitor of differentiation 1.
Transcription factor SOX-8.
Actin-related protein T1.
Bcl-2-modifying factor.
Collagen alpha-2(IX) chain precursor.
Heart- and neural crest derivatives-expressed protein 1.
Outer dense fiber protein 1.
Netrin-G1 precursor (Laminet-1).
Collagen alpha-1(IX) chain precursor.
Growth arrest and DNA-damage-inducible protein.
S100 calcium-binding protein A8 (Calgranulin-A).
T-box transcription factor TBX20.
Transcription factor GATA-6 (GATA-binding factor 6).
F-box only protein 2.
Noggin precursor.
Mothers against decapentaplegic homolog 6.
procollagen, type IX, alpha 3.
Netrin receptor UNC5B precursor.
Angiopoietin-1 precursor (ANG-1).
Platelet-derived growth factor receptor-like protein.
Endothelial transcription factor GATA-2.
Insulin-like growth factor-binding protein 7 precursor.
Regulator of G-protein signaling 5.
Insulin gene enhancer protein ISL-1.
Bone morphogenetic protein 4 precursor.
Trans-acting T-cell-specific transcription factor GATA-3.
Secretin precursor.
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